Company lands $15m to advance medicines that boo
Author: Michael
On a mission to extend healthy lifespan, startup
Study shows that mitochondrial-targeted sulfide
Vitalia CEO Niklas Anzinger on creating lasting
Startup secures $5.
Announced merger aims to foster collaboration an
New research shows that stochastic variation alo
Delivering siRNA therapies to the kidney could p
A novel peptide could provide a more targeted ap
Scott Fulton explores how emerging technologies